Elon Musk’s Drug Use Is the Latest Headache for Tesla’s Board
Elon Musk’s reported drug use has Tesla Inc. board members facing a familiar quandary: having to decide what, if anything, to do.
Recent
Vocal Critic Ackman Has Two Down, One to Go - MIT
Bill Ackman is now shifting his focus towards the President of the Massachusetts Institute of Technology (MIT), Sally Kornbluth.
Fisher Investments Refutes Sale Rumors
Fisher Investments officially refuted recent WSJ article claiming firm was in negotiations with Advent International for a potential sale.
Tingo Group Founder Hit by Hindenburg Now Charged Criminally
Tingo Group founder was charged with securities fraud in New York, accused of orchestrating a massive scheme to inflate the company’s finances.
US Debt Escalating at An Alarming Pace
Economist Darrell Spence from the renowned US asset manager highlighted in an October research note the critical evolution of US debt dynamics.
Two Sigma Researcher Fights Hedge Fund Over Blame for US$170 Mil Loss
Two Sigma Investments quantitative researcher fighting claims he made unauthorized changes to quantitative models leading to U.S. $170M client losses.
It Was a Tough Year for Almost Every Bank Not Named JPMorgan
After year marred by biggest US bank failures since 2008 financial crisis nation’s largest lender is on familiar footing scooping up a weakened rival.
